Saaol Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.92 M
- Revenue Growth 222.17%
- Profit Growth 615.06%
- Ebitda 541.43%
- Net Worth 80.56%
- Total Assets 62.23%
About Saaol Pharma
Saaol Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 September 2014 and has a history of Ten years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹2.92 M.
Bimal Chhajer and Aditya Sethi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74140DL2014PTC271417
- Company No.
271417
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Saaol Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bimal Chhajer  | Director | 10-Sep-2014 | Current |
| Aditya Sethi | Director | 10-Sep-2014 | Current |
Financial Performance of Saaol Pharma.
Saaol Pharma Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 222.17% increase. The company also saw a substantial improvement in profitability, with a 615.06% increase in profit. The company's net worth Soared by an impressive increase of 80.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saaol Pharma?
In 2017, Saaol Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saaol Wellness Private LimitedBimal Chhajer is a mutual person
Saaol Services Private LimitedBimal Chhajer is a mutual person
Saaol Health Private LimitedBimal Chhajer is a mutual person
Jma Heart Health Private LimitedBimal Chhajer and Aditya Sethi are mutual person
Saaol Infotech Private LimitedBimal Chhajer and Aditya Sethi are mutual person
- Saaol Cardiac Services Private Limited
Bimal Chhajer is a mutual person
Charges (Loans)
₹2.92 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2021 | Hdfc Bank Limited | ₹2.92 M | Open |
How Many Employees Work at Saaol Pharma?
Unlock and access historical data on people associated with Saaol Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saaol Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saaol Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
